• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在使用基于体素的弥散张量成像个体分析方法的多发性硬化症患者中,开始使用芬戈莫德治疗后大脑的活性变化。

Active brain changes after initiating fingolimod therapy in multiple sclerosis patients using individual voxel-based analyses for diffusion tensor imaging.

作者信息

Senda Joe, Watanabe Hirohisa, Endo Kuniyuki, Yasui Keizo, Hawsegawa Yasuhiro, Yoneyama Noritaka, Tsuboi Takashi, Hara Kazuhiro, Ito Mizuki, Atsuta Naoki, Epifanio Bagarinao, Katsuno Masahisa, Naganawa Shinji, Sobue Gen

机构信息

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Neurology and Rehabilitation, Komaki City Hospital, Komaki, Japan.

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Brain and Mind Research Center, Nagoya University, Nagoya, Japan.

出版信息

Nagoya J Med Sci. 2016 Dec;78(4):455-463. doi: 10.18999/nagjms.78.4.455.

DOI:10.18999/nagjms.78.4.455
PMID:28008201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5159471/
Abstract

Voxel-based analysis (VBA) of diffusion tensor images (DTI) and voxel-based morphometry (VBM) in patients with multiple sclerosis (MS) can sensitively detect occult tissue damage that underlies pathological changes in the brain. In the present study, both at the start of fingolimod and post-four months clinical remission, we assessed four patients with MS who were evaluated with VBA of DTI, VBM, and fluid-attenuated inversion recovery (FLAIR). DTI images for all four patients showed widespread areas of increased mean diffusivity (MD) and decreased fractional anisotropy (FA) that were beyond the high-intensity signal areas across images. After four months of continuous fingolimod therapy, DTI abnormalities progressed; in particular, MD was significantly increased, while brain volume and high-intensity signals were unchanged. These findings suggest that VBA of DTI (e.g., MD) may help assess MS demyelination as neuroinflammatory conditions, even though clinical manifestations of MS appear to be in complete remission during fingolimod.

摘要

对多发性硬化症(MS)患者的扩散张量图像(DTI)进行基于体素的分析(VBA)以及基于体素的形态测量(VBM),能够灵敏地检测出作为大脑病理变化基础的隐匿性组织损伤。在本研究中,在芬戈莫德治疗开始时以及治疗四个月后临床缓解时,我们对四名MS患者进行了评估,采用了DTI的VBA、VBM以及液体衰减反转恢复(FLAIR)技术。所有四名患者的DTI图像均显示,平均扩散率(MD)增加且各向异性分数(FA)降低的区域广泛,这些区域超出了图像上的高强度信号区域。经过四个月的连续芬戈莫德治疗后,DTI异常情况有所进展;特别是,MD显著增加,而脑容量和高强度信号未发生变化。这些发现表明,DTI的VBA(例如MD)可能有助于将MS脱髓鞘评估为神经炎症状态,即便在芬戈莫德治疗期间MS的临床表现似乎已完全缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/30bee2a7b1d7/2186-3326-78-0455-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/f8d97f85353e/2186-3326-78-0455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/e828fa1d6f21/2186-3326-78-0455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/6d425c4e58ae/2186-3326-78-0455-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/30bee2a7b1d7/2186-3326-78-0455-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/f8d97f85353e/2186-3326-78-0455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/e828fa1d6f21/2186-3326-78-0455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/6d425c4e58ae/2186-3326-78-0455-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03a/5159471/30bee2a7b1d7/2186-3326-78-0455-g004.jpg

相似文献

1
Active brain changes after initiating fingolimod therapy in multiple sclerosis patients using individual voxel-based analyses for diffusion tensor imaging.在使用基于体素的弥散张量成像个体分析方法的多发性硬化症患者中,开始使用芬戈莫德治疗后大脑的活性变化。
Nagoya J Med Sci. 2016 Dec;78(4):455-463. doi: 10.18999/nagjms.78.4.455.
2
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.MRI 平均扩散率可检测多发性硬化症中的广泛脑退行性变。
J Neurol Sci. 2012 Aug 15;319(1-2):105-10. doi: 10.1016/j.jns.2012.04.019. Epub 2012 May 23.
3
Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study.肌萎缩侧索硬化症中进行性广泛性脑损伤:磁共振成像基于体素的形态测量和扩散张量成像研究
Amyotroph Lateral Scler. 2011 Jan;12(1):59-69. doi: 10.3109/17482968.2010.517850.
4
Evaluation of voxel-based group-level analysis of diffusion tensor images using simulated brain lesions.基于体素的弥散张量图像组水平分析的模拟脑损伤评估。
Neurosci Res. 2011 Dec;71(4):377-86. doi: 10.1016/j.neures.2011.09.006. Epub 2011 Sep 29.
5
A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.一种用于识别和表征神经精神性系统性红斑狼疮患者脑微结构变化的多模态磁共振成像方法。
Neuroimage Clin. 2015 May 16;8:337-44. doi: 10.1016/j.nicl.2015.05.002. eCollection 2015.
6
Clinical and radiological impact of liver transplantation for brain in cirrhosis patients without hepatic encephalopathy.肝移植对无肝性脑病的肝硬化患者脑部的临床及影像学影响
Clin Neurol Neurosurg. 2013 Nov;115(11):2341-7. doi: 10.1016/j.clineuro.2013.08.015. Epub 2013 Sep 10.
7
Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.多发性硬化症:应用弥散张量成像评估 T1 加权 MR 图像上的脑高信号病变。
J Magn Reson Imaging. 2010 Apr;31(4):789-95. doi: 10.1002/jmri.22103.
8
Differences in Gaussian diffusion tensor imaging and non-Gaussian diffusion kurtosis imaging model-based estimates of diffusion tensor invariants in the human brain.基于高斯扩散张量成像和非高斯扩散峰度成像模型的人脑扩散张量不变量估计差异。
Med Phys. 2016 May;43(5):2464. doi: 10.1118/1.4946819.
9
Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia.首发精神分裂症早期的灰白质体积和弥散张量成像(DTI)分析。
Schizophr Res. 2010 Feb;116(2-3):196-203. doi: 10.1016/j.schres.2009.10.002. Epub 2009 Oct 24.
10
The effect of template selection on diffusion tensor voxel-based analysis results.模板选择对弥散张量体素分析结果的影响。
Neuroimage. 2011 Mar 15;55(2):566-73. doi: 10.1016/j.neuroimage.2010.12.005. Epub 2010 Dec 10.

引用本文的文献

1
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia.芬戈莫德,一种鞘氨醇-1-磷酸(S1P)受体激动剂,对精神分裂症患者的脑白质微结构、认知和症状的影响。
Brain Imaging Behav. 2021 Aug;15(4):1802-1814. doi: 10.1007/s11682-020-00375-7.
2
Fingolimod-improved axonal and myelin integrity of white matter tracts associated with multiple sclerosis-related functional impairments.芬戈莫德改善多发性硬化症相关功能障碍与白质束相关的轴突和髓鞘完整性。
CNS Neurosci Ther. 2018 May;24(5):412-419. doi: 10.1111/cns.12796. Epub 2018 Jan 5.
3
The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

本文引用的文献

1
[A case of multiple sclerosis who relapsed early after fingolimod therapy introduced].
Rinsho Shinkeigaku. 2015;55(6):417-20. doi: 10.5692/clinicalneurol.cn-000515.
2
Fingolimod effect on brain volume loss independently contributes to its effect on disability.芬戈莫德对脑容量损失的作用独立地促成了其对残疾的作用。
Mult Scler. 2015 Jun;21(7):916-24. doi: 10.1177/1352458515569099. Epub 2015 Feb 6.
3
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.多发性硬化症中脑容量损失与临床及磁共振成像结果之间的相关性。
高级磁共振成像技术在多发性硬化症临床试验中的作用。
Neurotherapeutics. 2017 Oct;14(4):905-923. doi: 10.1007/s13311-017-0561-8.
Neurology. 2015 Feb 24;84(8):784-93. doi: 10.1212/WNL.0000000000001281. Epub 2015 Jan 28.
4
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy.一名多发性硬化症患者在服用芬戈莫德治疗期间及之后出现肿胀性脱髓鞘病变及恶性病程。
J Neurol Sci. 2014 Sep 15;344(1-2):193-7. doi: 10.1016/j.jns.2014.06.013. Epub 2014 Jun 17.
5
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.在多发性硬化症的 fingolimod 治疗起始后 Th17 和调节性 T 细胞的变化。
J Neuroimmunol. 2014 Mar 15;268(1-2):95-8. doi: 10.1016/j.jneuroim.2014.01.008. Epub 2014 Jan 23.
6
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.多发性硬化症:现有和新兴的疾病修正治疗方法和治疗策略。
Mayo Clin Proc. 2014 Feb;89(2):225-40. doi: 10.1016/j.mayocp.2013.11.002.
7
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.肿块样多发性硬化症和芬戈莫德:免疫疗法及意外后果。
Neurology. 2013 Nov 5;81(19):1648-9. doi: 10.1212/01.wnl.0000435305.95271.84. Epub 2013 Oct 4.
8
Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.评估多发性硬化症患者的灰质和白质损伤与运动和认知障碍之间的相关性。
PLoS One. 2013 May 16;8(5):e63250. doi: 10.1371/journal.pone.0063250. Print 2013.
9
Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.芬戈莫德疗法对多发性硬化症患者磁共振成像结果的影响。
Arch Neurol. 2012 Oct;69(10):1259-69. doi: 10.1001/archneurol.2012.1051.
10
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.MRI 平均扩散率可检测多发性硬化症中的广泛脑退行性变。
J Neurol Sci. 2012 Aug 15;319(1-2):105-10. doi: 10.1016/j.jns.2012.04.019. Epub 2012 May 23.